Cost Effectiveness of Pneumococcal Vaccination for Infants and Children with the Conjugate Vaccine PnC-7 in Germany
Background: The introduction of the conjugate vaccine PnC-7 implies that a pneumococcal vaccine is available, for the first time, which also gives children under the age of 2 years reliable protection against invasive pneumococcal infections and offers some protection against non-invasive pneumococcal infections.
Objective and perspective: In the context of a multiple-period Markov model, a cost-effectiveness analysis of a recommendation for general pneumococcal vaccination in Germany for infants and children under the age of 2 years was performed from the healthcare payer, public authority and societal perspectives.
Design: Various published data on age-specific incidence rates, mortality rates, efficacy of the conjugate vaccine PnC-7 and treatment costs of pneumococcal infections were incorporated into a Markov model to quantify the consequences of vaccinating versus not vaccinating.
Results: From a German healthcare payers’ perspective, general vaccination with the conjugate vaccine would redeem 51.1% of the vaccination costs due to avoidable treatment costs, whereas, from a broader point of view, the benefits, expressed in monetary terms, would exceed the cost of vaccination. The conjugate vaccine would require an investment of €72 866 per life-year saved (discounted, healthcare payers’ viewpoint). Besides this benchmark, there are further outcome measures which cannot be ignored by those deciding on a general vaccination recommendation: 450 000 preventable episodes of illness and 134 cases of sequelae which can be prevented.
Conclusions: The vaccination with the conjugate vaccine PnC-7 is cost saving from a broader perspective and the results should not be ignored by policy makers in regard to a general vaccination recommendation.
KeywordsOtitis Medium Cochlear Implant Conjugate Vaccine Invasive Pneumococcal Disease Cochlear Implantation
The authors thank Wyeth-Pharma Germany for providing us with information about practitioners’ prescription and retail prices, for organizing interdisciplinary expert meetings and for their financial support of travel expenses and translation. The authors have provided no information on conflicts of interest directly relevant to the content of this study.
- 1.Robert Koch Institut (RKI). Immunisation recommendations of the Standing Committee on Immunisation (STIKO) at Robert Koch-Institut/Stand: Juli 2001. Epidemiol Bull 2001; 28: 203–18Google Scholar
- 3.Hanoveraner Consensus Group. German recommendations regarding to health-economic evaluation: revised version of the Hanoverian Consensus [in German]. Gesundheitsökonomie and Qualitätsmanagement 1999; 4: A62–5Google Scholar
- 4.Adam D. Pneumococcal illnesses (meningitis, pneumonia, sepsis) in infancy from clinical view [in German]. In: Stdck B, Voβ H, editors. Pneumococcal illnesses of babies and toddlers [in German]. Marburg: Verlag im Kilian, 2001: 11–14Google Scholar
- 8.Siedler A. Illnesses by pneumococcus: epidemiological situation in Germany (Emphasis invasive illnesses) [in German]. In: Stuck B, Voβ H, editors. Pneumococcal illnesses of babies and toddlers [in German]. Marburg: Verlag im Kilian, 2001: 44–53Google Scholar
- 12.Müller-Werdan A, Werdan K. Therapy of sepsis — a position reckoning [in German]. Arzneimitteltherapie 1999; 4: 126Google Scholar
- 13.Schmöle-Thoma B. Efficacy and compatibility of the pneumococcal conjugate vaccines [in German]. In: Stuck B, Voβ H, editors. Pneumococcal illnesses of babies and toddlers [in German]. Marburg: Verlag im Kilian, 2001: 72–78Google Scholar
- 14.Homepage of IMS Health [online]. Available from URL: http://www.imshealth.de [Accessed 2003 Jan 30]
- 17.Louvois J de, Bedford H, Peckham C, et al. Epidemiology of infantile meningitis: results from a five-year prospective follow-up of 1721 survivors of meningitis in the first year of life [abstract 12]. 19th Annual Meeting of the European Society for Paediatric Infectious Diseases (ESPID); 2001 Mar 26–28; IstanbulGoogle Scholar
- 18.Statistisches Bundesamt (Federal Statistical Office), editor. Health report for Germany [in German]. Wiesbaden: Metzler-Poeschel, 1998: 235Google Scholar
- 23.Zok K. Hearing aids in competition. Channels of supply in comparison [in German]. Bonn: Research Institute of the Local Healthcare Funds (WIdO), 2001Google Scholar
- 24.Schulze-Gattermann H. Cost benefit-analysis of Cochlear implantation with children [dissertation] [in German]. Hanover: Medical School of Hanover, 2000Google Scholar
- 26.Ley S, Quasi U. Summary of the most important results of the workshop [in German]. In: Stuck B, Vob H, editors. Pneumococcal illnesses of babies and toddlers [in German]. Marburg: Verlag im Kilian, 2001: 83–93Google Scholar
- 27.Zi Koeln homepage. Available from URL: http://www.zikoeln.de [Accessed 2003 Jan 30]
- 28.German Social Court. Judgement in the law case. Reference: B 6 KA 14/98 R from 1999 Aug 25Google Scholar
- 29.Federal Statistical Office Germany, editor. Health care, Fachserie 12, Reihe 6.2, Diagnostic data of the inpatients [in German]. Wiesbaden: Metzler-Poeschel, 1998Google Scholar
- 31.Federal State Audit Court of Lower Saxony. Message to the Ministry for Women’s Issues and Social Affairs of Lower Saxony, Ministry of Education and Arts of Lower Saxony, regional authorities for Central Social Functions: about the cross section check of the regional education centers [in German]. Hildesheim: Selfprint, ed. 1999Google Scholar
- 32.Schulenburg JM Graf v d, Greiner W, Schöffski O. Recommendations regarding to health-economic evaluation: Hanoverian Consensus [in German]. Zeitschrift für Allgemeinmedizin 1996; 72: 485–90Google Scholar
- 33.Federal Statistical Office Germany. National accounts: important overall economic sizes and gainful employment [in German]. Wiesbaden, 2000. Available from URL: http://www.destatis.de/basis/d/vgr/vgrtabl0.htm and from from URL: http://www.destatis.de/basis/d/erwerb/erwerbtabl.htm [Accessed 2002 Jan 30]
- 34.Federal Statistical Office Germany. Micro censuses 1998: labour participation of mothers. Approximately 60% of the mothers with children less than 18 years are gainfully employed [in German]. Wiesbaden, 1999. Available from URL: Available from URL: http://www.destatis.de/presse/deutsch/pm1996/p0700031.htm [Accessed 2002 Jan 30]
- 37.Whitney CG, Farley MM, Hadler J, et al. Decline in invasive pneumococcal disease in the US in 2000: an effect of pneumococcal conjugate vaccine? [abstract]. Centers for Disease Control and Prevention (CDC). Atlanta (GA); 2 Emerging Infections Program, ICAAC 2001, G2041Google Scholar